Prilenia

Industry · 8 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS Amyotrophic Lateral Sclerosis	Phase 3	2026-02-01
Completed	PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD Huntington Disease	Phase 3	2020-10-16
Terminated	A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa Parkinson Disease	Phase 2	2019-05-22
Completed	A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Vol Health Volunteers, Huntington Disease	Phase 1	2017-04-19
Terminated	A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease Huntington's Disease	Phase 2	2015-09-24
Completed	A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patien Huntington's Disease	Phase 2	2014-02-28
Completed	Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease Huntington Disease	Phase 2	2011-03-24
No Longer Available	A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral S Amyotrophic Lateral Sclerosis	—	—